Search
Patexia Research
Case number 1:22-cv-00192

Pfizer Inc. et al v. Teva Pharmaceuticals USA, Inc. > Documents

Date Field Doc. No.Description (Pages)
Apr 26, 2022 N/A Terminated Case (0)
Docket Text: CASE CLOSED per [9] Notice of Voluntary Dismissal. (kmd)
Apr 26, 2022 9 Notice of Voluntary Dismissal (2)
Docket Text: NOTICE of Voluntary Dismissal by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc. (Dellinger, Megan)
Apr 26, 2022 10 Main Document (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,639,309 B2. (Attachments: # (1) Notice of Voluntary Dismissal)(kmd)
Apr 26, 2022 10 Notice of Voluntary Dismissal (2)
Mar 31, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [8] STIPULATION TO EXTEND TIME for Defendant Teva Pharmaceuticals USA, Inc. to move, answer, or otherwise respond to the Complaint to May 2, 2022, filed by Teva Pharmaceuticals USA, Inc. Reset Answer Deadlines: Teva Pharmaceuticals USA, Inc. answer due 5/2/2022. Ordered by Judge Colm F. Connolly on 3/31/2022. (kmd)
Mar 31, 2022 8 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME for Defendant Teva Pharmaceuticals USA, Inc. to move, answer, or otherwise respond to the Complaint to May 2, 2022 - filed by Teva Pharmaceuticals USA, Inc.. (Brauerman, Stephen)
Mar 11, 2022 N/A Case Assigned/Reassigned (0)
Docket Text: Case Reassigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:21-cv-00022-CFC, 1:21-cv-01427-CFC, 1:22-cv-00191-CFC, 1:22-cv-00192-CFC (rjb)
Mar 9, 2022 7 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by Pfizer Inc., C.P. Pharmaceuticals International C.V., PF PRISM C.V., PF PRISM IMB B.V., PBG Puerto Rico LLC. Teva Pharmaceuticals USA, Inc. served on 3/9/2022, answer due 3/30/2022. (Dellinger, Megan)
Feb 16, 2022 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:22-cv-00191-LPS, 1:22-cv-00192-LPS (rjb)
Feb 11, 2022 1 Main Document (9)
Docket Text: COMPLAINT filed against Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3801826.) - filed by Pfizer Inc., C.P. Pharmaceuticals International C.V., PF PRISM C.V., PF PRISM IMB B.V., PBG Puerto Rico LLC. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(twk)
Feb 11, 2022 1 Exhibit A (43)
Feb 11, 2022 1 Civil Cover Sheet (2)
Feb 11, 2022 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk)
Feb 11, 2022 3 ANDA Form (2)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: January 3, 2022. Date of Expiration of Patent: March 14, 2034. Thirty Month Stay Deadline: 7/3/2024. (twk)
Feb 11, 2022 4 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,639,309 B2. (twk)
Feb 11, 2022 5 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V. - filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V. (twk)
Feb 11, 2022 6 Summons Issued (2)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Teva Pharmaceuticals USA, Inc. on 2/14/2022. (twk)
Feb 11, 2022 1 Complaint* (1)
Menu